Your oncologist will monitor the effectiveness of anastrozole and ribociclib (Kisqali) through regular follow-up appointments and tests. These medications are part of the systemic therapy approach used to help prevent cancer from returning after primary treatments like surgery, chemotherapy, and radiation.
For stage 2 Show Full Answer
Your oncologist will monitor the effectiveness of anastrozole and ribociclib (Kisqali) through regular follow-up appointments and tests. These medications are part of the systemic therapy approach used to help prevent cancer from returning after primary treatments like surgery, chemotherapy, and radiation.
For stage 2 breast cancer patients, monitoring typically includes:
• Regular physical examinations
• Blood tests to check hormone levels
• Imaging tests as needed (mammograms, ultrasounds, or MRIs)
• Monitoring of any symptoms or side effects Since you've mentioned testing for other cancers, it's important to focus on your breast cancer follow-up care first. Your oncology team will create a specific surveillance plan based on your individual case and risk factors. They will determine what additional screening may be appropriate for you during your regular follow-up visits. The most important thing is to maintain your scheduled appointments and report any new symptoms to your healthcare team promptly.
August 11, 2025